Form 4: Algorhythm Director Scott Thorn Receives Equity Awards

Algorhythm Holdings, Inc. Director Scott Thorn was granted 19,532 restricted shares and options for 39,063 shares under the 2022 Equity Incentive Plan.

Summary

• Scott Thorn, a Director and 10% Owner of Algorhythm Holdings, Inc. (RIME), received a restricted stock award (RSA) of 19,532 shares of common stock.
• The RSA vests in equal quarterly installments over a period of one year from the grant date of November 20, 2025.
• Thorn also received a non-qualified stock option to purchase 39,063 shares of the Issuer's common stock.
• The stock option has an exercise price of $1.28 per share and vests in equal quarterly installments over one year from the grant date.
• The stock option's expiration date is November 20, 2035.
• Both the RSA and the stock option were granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it represents routine compensation designed to align director interests with shareholder value, without indicating any immediate operational or financial shifts.

Positives

• The equity awards align the interests of Director Scott Thorn with those of the company's shareholders, incentivizing long-term performance.
• The grants are made under an existing and approved equity incentive plan, indicating structured compensation practices.

Negatives

• The issuance of new shares upon vesting of the RSA and exercise of options could lead to minor dilution for existing shareholders.

Risks

• Potential future dilution of existing shareholder equity if the stock options are exercised and restricted shares vest.
• The value of the awards is tied to the company's stock performance, exposing the recipient to market volatility.

Future Outlook

The vesting schedules for both the restricted stock award and the stock options, occurring in equal quarterly installments over one year from the grant date, indicate a forward-looking incentive structure designed to retain and motivate the director over the near term.

Industry Context

StockSavvy.ai notes that granting equity awards such as restricted stock and stock options to directors is a common practice across various industries, particularly in technology and growth-oriented companies. This strategy is widely adopted to align the interests of management and board members with those of shareholders, fostering long-term value creation and retention.

Comparison to Industry Standards

• Equity compensation for directors, including restricted stock and stock options, is a standard practice in publicly traded companies, aligning director incentives with shareholder value.
• The vesting schedule of one year in quarterly installments is a common approach to ensure continued engagement and performance over a defined period.
• The use of an established '2022 Equity Incentive Plan' is typical for companies to manage and administer their equity compensation programs in a structured and compliant manner.

Corporate Governance

Related Party Transactions

• The transaction involves the issuance of equity awards to Scott Thorn, a Director and 10% Owner of Algorhythm Holdings, Inc., making it a related party transaction.

Stakeholder Impact

• Shareholders: Potential for minor dilution from future share issuance, but also benefit from increased alignment of director incentives with company performance.
• Director (Scott Thorn): Receives significant equity-based compensation, incentivizing long-term commitment and performance.

Next Steps

• The restricted stock award will vest in equal quarterly installments over one year from November 20, 2025.
• The non-qualified stock option will vest and become exercisable in equal quarterly installments over one year from November 20, 2025.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation for a director and does not present new information that would fundamentally alter the company's valuation or operational outlook. While it aligns management interests, it does not provide a basis for a change in investment recommendation based solely on this filing.

Keywords

Algorhythm Holdings, RIME, Scott Thorn, SEC Form 4, Insider Transaction, Restricted Stock Award, Stock Option, Equity Incentive Plan, Director Compensation, Shareholder Alignment